NAMS
NASDAQ · Biotechnology
Newamsterdam Pharma Co Nv
$38.73
+3.88 (+11.13%)
Performance
1D
—
1W
—
1M
—
3M
+10.66%
6M
-2.91%
1Y
+101.51%
YTD
+10.03%
Open$34.85
Previous Close$34.85
Day High$41.17
Day Low$34.85
52W High$42.00
52W Low$16.79
Volume—
Avg Volume1.22M
Market Cap4.07B
P/E Ratio—
EPS$-1.72
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$34.11
Above
SMA 200
$28.53
Above
RSI (14)
66.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
-6.0% upside
Current
$38.73
$38.73
Target
$36.39
$36.39
$23.00
$36.39 avg
$47.36
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 19.99M | 32.58M | 2.72B |
| Net Income | -181,046,157 | -265,636,682 | 249.35M |
| Profit Margin | -905.7% | -860.5% | 9.2% |
| EBITDA | -216,958,747 | -336,013,709 | 355.91M |
| Free Cash Flow | — | — | 147.67M |
| Rev Growth | -38.7% | -38.7% | +24.9% |
| Debt/Equity | — | — | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |